Search Results

PIOVIB 15

PIOVIB 15

PIOGLITAZONE 15mg. IP

Send Enquiry

CURE

Tablets

Packaging and packing Type

Blister | 10x10

MRP :

₹68

PTR :

₹48.57

PTS :

₹43.71

An anti-hyperglycemic agent that is primarily used for the management of type 2 diabetes mellitus. An oral antidiabetic agent that decreases insulin ... Read More

Composition

PIOGLITAZONE 15mg. IP

Send Enquiry

India’s Largest Pharma Franchise

100%

Genuine Products

Secure

Payments

24 x 7

Customer Support

About the product

Description

An anti-hyperglycemic agent that is primarily used for the management of type 2 diabetes mellitus. An oral antidiabetic agent that decreases insulin resistance in adipose tissue, liver, and muscles. (Pablos-Velasco, 2010) Improves sensitivity to insulin in muscle and adipose tissue and inhibits hepatic gluconeogenesis. (Pablos-Velasco, 2010) Effectively improves blood glucose levels, long-term glucose control, and the lipid profile in patients with type 2 diabetes mellitus. (Andreas Pfützner, 2006) An attractive and effective treatment option for managing type 2 diabetes mellitus. (Andreas Pfützner, 2006) Significantly improves HbA1c and FPG while producing beneficial effects on serum lipids in patients with type 2 diabetes. (S Aronoff, 2000) Exerts additional beneficial vascular effects in patients with type 2 diabetes mellitus. (Keiichiro Harashima, 2009) A well-tolerated agent in patients with varying degrees of renal impairment. (Klemens Budde, 2003) Improves insulin resistance in Type 2 diabetes without inducing insulin secretion from pancreatic β-cells, thereby reducing the risk of hypoglycemia. (Klemens Budde, 2003) Controls blood sugar levels by increasing the body's sensitivity to insulin, a hormone that regulates glucose metabolism. Ameliorates glycaemic control, by lowering fasting and postprandial blood glucose levels, and improves insulin sensitivity. (Michaela Diamant, 2003) Alleviates insulin resistance associated with type 2 diabetes and improves hyperglycemia, reducing HbA1c levels. (Toyota, 2001) Offers an effective approach to reducing measures of cardiovascular risk and arteriosclerosis. (John Waugh, 2006) A more beneficial treatment option for managing coronary artery disease progression in individuals with type 2 diabetes. (Steven E Nissen & Investigators, 2008)

Side Effects

Weight gain, Edema, Anemia, Low blood sugar, Headache, Loss of appetite

Indication

Type 2 diabetes mellitus

Important Notice

Temp data

Storage Condition

Product details for storage condition Product details for storage condition Product details for storage condition Product details for storage condition

Similar Products

No products found.

Looking into the future of healthcare

Contact

Plot No 4, HSIIDC IT PARK, Sector 22,Panchkula, Haryana, India 134109

Phone: 9888988858

Business Hours

Mon-Sat: 9AM to 6PM

Franchise Enquiry

Request a callback to get more information about becoming a PCD Franchise Owner***

    Send Enquiry

    Request a callback to get more information about becoming a PCD Franchise Owner